Warning: The NCBI web site requires JavaScript to function. more...
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.
Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, Gerald WL, Bornmann W, Bromberg JF.
Breast Cancer Res. 2007;9(3):R32.
Related citations
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B, Bromberg JF.
J Clin Invest. 2007 Dec;117(12):3846-56.
STAT3 can be activated through paracrine signaling in breast epithelial cells.
Lieblein JC, Ball S, Hutzen B, Sasser AK, Lin HJ, Huang TH, Hall BM, Lin J.
BMC Cancer. 2008 Oct 21;8:302.
Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL, Yeh J, Van Waes C, Chen Z.
Mol Cancer Ther. 2006 Jan;5(1):8-19.
CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS, DeWille JW.
J Cell Biochem. 2004 Nov 1;93(4):830-43.
Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.
Vultur A, Cao J, Arulanandam R, Turkson J, Jove R, Greer P, Craig A, Elliott B, Raptis L.
Oncogene. 2004 Apr 8;23(15):2600-16.
Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
Kreis S, Munz GA, Haan S, Heinrich PC, Behrmann I.
Mol Cancer Res. 2007 Dec;5(12):1331-41.
17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.
Wang Y, Ma X, Yan S, Shen S, Zhu H, Gu Y, Wang H, Qin G, Yu Q.
Cancer Res. 2009 Sep 15;69(18):7302-10. Epub 2009 Aug 25.
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG, Mercado-Uribe I, Yang G, Bast RC Jr, Amin HM, Lai R, Liu J.
Cancer. 2006 Dec 1;107(11):2730-40.
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, Abbruzzese JL, Hortobagyi GN, Hung MC.
Cancer Res. 2007 Oct 1;67(19):9066-76.
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV.
Clin Cancer Res. 2006 Sep 1;12(17):5055-63.
Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
Pedranzini L, Dechow T, Berishaj M, Comenzo R, Zhou P, Azare J, Bornmann W, Bromberg J.
Cancer Res. 2006 Oct 1;66(19):9714-21.
The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
Zoubeidi A, Rocha J, Zouanat FZ, Hamel L, Scarlata E, Aprikian AG, Chevalier S.
Mol Cancer Res. 2009 Jan;7(1):142-55.
Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.
Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA.
Clin Cancer Res. 2006 Jan 1;12(1):20-8.
Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC, Cheng G, Lin J.
Biochem Biophys Res Commun. 2005 Sep 23;335(2):292-9.
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.
Lam LT, Wright G, Davis RE, Lenz G, Farinha P, Dang L, Chan JW, Rosenwald A, Gascoyne RD, Staudt LM.
Blood. 2008 Apr 1;111(7):3701-13. Epub 2007 Dec 26.
Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
Selander KS, Li L, Watson L, Merrell M, Dahmen H, Heinrich PC, Müller-Newen G, Harris KW.
Cancer Res. 2004 Oct 1;64(19):6924-33.
JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Song L, Rawal B, Nemeth JA, Haura EB.
Mol Cancer Ther. 2011 Mar;10(3):481-94. Epub 2011 Jan 7.
Activation of the signal transducer and activator of transcription 3 pathway up-regulates estrogen receptor-beta expression in lung adenocarcinoma cells.
Wang HC, Yeh HH, Huang WL, Lin CC, Su WP, Chen HH, Lai WW, Su WC.
Mol Endocrinol. 2011 Jul;25(7):1145-58. Epub 2011 May 5.
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
Galdiero M, Vitiello M, D'Isanto M, Raieta K, Galdiero E.
Cytokine. 2006 Dec;36(5-6):218-28. Epub 2007 Jan 26.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on